Advertisement
U.S. markets closed
Advertisement

Rapid Micro Biosystems, Inc. (RPID)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
1.1200-0.0100 (-0.88%)
At close: 02:31PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
Previous Close1.1300
Open1.1404
Bid1.1000 x 1200
Ask1.1400 x 900
Day's Range1.1100 - 1.1404
52 Week Range0.8300 - 1.8700
Volume1,885
Avg. Volume24,736
Market Cap47.487M
Beta (5Y Monthly)1.30
PE Ratio (TTM)N/A
EPS (TTM)-1.3400
Earnings DateNov 03, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.88
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RPID

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Rapid Micro Biosystems, Inc.
    CTKB: Raising target price to $6.00CYTEK BIOSCIENCES INC has an Investment Rating of SELL; a target price of $6.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • GlobeNewswire

    Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

    LOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences in New York, NY: Stifel 2023 Healthcare ConferenceQuestion-and-answer session with analyst on Wednesday, November 15th

  • Insider Monkey

    Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q3 2023 Earnings Call Transcript

    Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q3 2023 Earnings Call Transcript November 3, 2023 Rapid Micro Biosystems, Inc. beats earnings expectations. Reported EPS is $-0.31086, expectations were $-0.32. Operator: Thank you for holding, and welcome, everyone, to the Rapid Micro Biosystems’ Third Quarter 2023 Earnings Call. All lines have been placed on mute to prevent any […]

  • Zacks

    Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates

    Rapid Micro Biosystems, Inc. (RPID) delivered earnings and revenue surprises of 3.12% and 11.22%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?